Drug · CHEMBL92

DOCETAXEL ANHYDROUS

7 sourcespipelines-2026-09-18-0.3.1

Cite this record

ConductScience Library. DOCETAXEL ANHYDROUS. Drugs and targets, record CHEMBL92. Release pipelines-2026-09-18-0.3.1, 18 Sept 2026. https://conductscience.org/library/drugs/CHEMBL92

On this page

Drug

Names and IDs as ChEMBL gives them, through Open Targets.

Name: DOCETAXEL ANHYDROUS; ChEMBL
ChEMBL ID: CHEMBL92; ChEMBL
Type: Small molecule; ChEMBL
Brand names: Docefrez, Docetaxel kabi, Docetaxel mylan, Docetaxel teva pharma, Docetaxel winthrop; ChEMBL
Other names: Bind 014, CKD-810, Cabazitaxel metabolite (rp56976), Docetaxel kabi, Docetaxel mylan, Docetaxel teva pharma, Docetaxel, anhydrous, NSC-628503, Rp56976; ChEMBL
Other form: DOCETAXEL, CHEMBL3545252; Drugs and targets
DrugBank: DB01248; DrugBank
InChIKey: ZDZOTLJHXYCWBA-VCVYQWHSSA-N; ChEMBL
Open Targets' highest stage: Unknown, as Open Targets' drug record gives it; Open Targets

Targets30

The targets ChEMBL's mechanism records give for the drug, through Open Targets. A mechanism record says what the drug acts on, not how strongly.

Target	Protein	Mechanism	Action	Gene in Genes
TUBA1A	Tubulin	Tubulin stabiliser	STABILISER	https://conductscience.org/library/genes/7846
TUBA1A	Tubulin	Tubulin inhibitor	INHIBITOR	https://conductscience.org/library/genes/7846
TUBA1B	Tubulin	Tubulin stabiliser	STABILISER	https://conductscience.org/library/genes/10376
TUBA1B	Tubulin	Tubulin inhibitor	INHIBITOR	https://conductscience.org/library/genes/10376
TUBA1C	Tubulin	Tubulin stabiliser	STABILISER	https://conductscience.org/library/genes/84790
TUBA1C	Tubulin	Tubulin inhibitor	INHIBITOR	https://conductscience.org/library/genes/84790
TUBA3C	Tubulin	Tubulin stabiliser	STABILISER	https://conductscience.org/library/genes/7278
TUBA3C	Tubulin	Tubulin inhibitor	INHIBITOR	https://conductscience.org/library/genes/7278
TUBA3E	Tubulin	Tubulin stabiliser	STABILISER	https://conductscience.org/library/genes/112714
TUBA3E	Tubulin	Tubulin inhibitor	INHIBITOR	https://conductscience.org/library/genes/112714

1 to 10 of 30Source ChEMBL

See all 30 targets

Diseases0

The diseases Open Targets' clinical reports study the drug for, the most trial reports first. The stage is Open Targets', the highest any of its sources reports for the pair, and each row names the sources that report it.

None in this release.

Trials0

Trials whose record names the drug by a name ChEMBL states, posted results first, then the largest. Open Targets read each trial's text to find its drugs.

None in this release.

Comparisons in its trials0

Comparisons Trial comparisons calculated in the trials whose record names the drug, most participants first. A comparison in one of its trials does not always compare the drug, so read the two groups.

None in this release.

Papers from its trials0

The papers the trials whose record names the drug list on ClinicalTrials.gov as their results (RESULT) or as drawn from them (DERIVED), results first, newest first.

None in this release.

Tests in its trials0

The tests ConductCognition runs that the trials whose record names the drug name in their registered outcomes, as ScienceGraph matched them. ConductCognition's list names the tests it runs, not every test a trial used.

None in this release.

Data dates

The date of each source this release read.

Open Targets: 2026-09-18; Open Targets
ClinicalTrials.gov: 2026-11-05; ClinicalTrials.gov
Results, from AACT: 2026-03-23; AACT
Papers the trials list, from Trials: 2026-11-12; Trials
Comparisons, from Trial comparisons: 2026-03-23; Trial comparisons
Tests named in the trials, as ScienceGraph matched them: 2026-11-12; ConductCognition

Sources 7

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ChEMBL, through Open TargetsCC BY-SA 3.0
ConductCognition's list of its testsOur own data
ClinicalTrials.govNo license stated
NLM's MeSHNLM's terms
Open TargetsCC0 1.0
PubMedNLM's terms

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ConductCognition's list of its testsOur own data: ConductCognition's list of its tests, https://conductcognition.com
ClinicalTrials.govnone stated
NLM's MeSHNLM's
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PubMedNLM's terms

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this drug from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/drugs/v1/CHEMBL92

GET https://conductscience.org/api/drugs/v1/CHEMBL92/targets?page=2

API reference For AI assistants